If a variant has more than one submission, it may be counted in more than one significance column. If this is the
case, the total number of variants will be less than the sum of the other cells.
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
not provided |
total |
229
|
36
|
905
|
669
|
64
|
1
|
1823
|
Gene and significance breakdown #
Total genes and gene combinations: 6
Gene or gene combination |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
not provided |
total |
NF2
|
222
|
36
|
894
|
669
|
60
|
1
|
1801
|
LOC130067184, NF2
|
0 |
0 |
11
|
0 |
4
|
0 |
15
|
LOC130067183, LOC130067184, NF2
|
4
|
0 |
0 |
0 |
0 |
0 |
4
|
AP1B1, ASCC2, C22orf31, CABP7, CCDC117, CHEK2, EMID1, EWSR1, GAS2L1, HSCB, KREMEN1, MTMR3, NEFH, NF2, NIPSNAP1, RASL10A, RFPL1, RFPL1S, RHBDD3, THOC5, UQCR10, XBP1, ZMAT5, ZNRF3
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
AP1B1, C22orf31, CCDC117, CHEK2, EMID1, EWSR1, GAS2L1, HSCB, KREMEN1, NEFH, NF2, NIPSNAP1, RASL10A, RFPL1, RFPL1S, RHBDD3, THOC5, XBP1, ZNRF3
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
AP1B1, EMID1, EWSR1, GAS2L1, NEFH, NF2, NIPSNAP1, RASL10A, RFPL1, RFPL1S, RHBDD3, THOC5
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
Submitter and significance breakdown #
Submitter |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
not provided |
total |
Labcorp Genetics (formerly Invitae), Labcorp
|
182
|
20
|
691
|
630
|
27
|
0 |
1550
|
All of Us Research Program, National Institutes of Health
|
0 |
3
|
175
|
80
|
5
|
0 |
263
|
Illumina Laboratory Services, Illumina
|
0 |
0 |
129
|
19
|
32
|
0 |
180
|
Genome-Nilou Lab
|
9
|
1
|
79
|
19
|
14
|
0 |
122
|
Mendelics
|
12
|
1
|
15
|
4
|
5
|
0 |
37
|
OMIM
|
14
|
0 |
0 |
0 |
0 |
0 |
14
|
Color Diagnostics, LLC DBA Color Health
|
0 |
0 |
2
|
7
|
4
|
0 |
13
|
Center for Human Genetics, Inc, Center for Human Genetics, Inc
|
6
|
6
|
0 |
0 |
0 |
0 |
12
|
Genetics and Molecular Pathology, SA Pathology
|
9
|
0 |
3
|
0 |
0 |
0 |
12
|
KCCC/NGS Laboratory, Kuwait Cancer Control Center
|
0 |
0 |
0 |
3
|
8
|
0 |
11
|
St. Jude Molecular Pathology, St. Jude Children's Research Hospital
|
2
|
0 |
7
|
0 |
0 |
0 |
9
|
Baylor Genetics
|
2
|
1
|
4
|
0 |
0 |
0 |
7
|
Revvity Omics, Revvity
|
1
|
0 |
6
|
0 |
0 |
0 |
7
|
ENT and Head and Neck Research Center and Department, The Five Senses Health Institute, Iran University of Medical Sciences
|
7
|
0 |
0 |
0 |
0 |
0 |
7
|
Juno Genomics, Hangzhou Juno Genomics, Inc
|
3
|
2
|
1
|
0 |
0 |
0 |
6
|
MGZ Medical Genetics Center
|
1
|
0 |
2
|
0 |
0 |
0 |
3
|
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
|
2
|
1
|
0 |
0 |
0 |
0 |
3
|
Clinical Genomics Laboratory, Washington University in St. Louis
|
1
|
0 |
2
|
0 |
0 |
0 |
3
|
New York Genome Center
|
0 |
0 |
3
|
0 |
0 |
0 |
3
|
Clinical Molecular Genetics Laboratory, Johns Hopkins All Children's Hospital
|
2
|
0 |
0 |
0 |
0 |
0 |
2
|
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute
|
2
|
0 |
0 |
0 |
0 |
0 |
2
|
Genomic Medicine Center of Excellence, King Faisal Specialist Hospital and Research Centre
|
2
|
0 |
0 |
0 |
0 |
0 |
2
|
Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics
|
2
|
0 |
0 |
0 |
0 |
0 |
2
|
Department of Pediatrics, Memorial Sloan Kettering Cancer Center
|
2
|
0 |
0 |
0 |
0 |
0 |
2
|
Swedish Neurofibromatosis Center, Swedish Medical Center
|
0 |
2
|
0 |
0 |
0 |
0 |
2
|
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
UAB Medical Genomics Laboratory, UAB Medicine
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
Genomic Research Center, Shahid Beheshti University of Medical Sciences
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
Knight Diagnostic Laboratories, Oregon Health and Sciences University
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
Center of Genomic medicine, Geneva, University Hospital of Geneva
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
Bioscientia Institut fuer Medizinische Diagnostik GmbH, Sonic Healthcare
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
Department of Pathology and Laboratory Medicine, Sinai Health System
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
Diagnostics Services (NGS), CSIR - Centre For Cellular And Molecular Biology
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
3billion, Medical Genetics
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
Hereditary Cancer Clinic, Medical College of Georgia
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
GenomeConnect - Invitae Patient Insights Network
|
0 |
0 |
0 |
0 |
0 |
1
|
1
|
Neuberg Centre For Genomic Medicine, NCGM
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
Cell and Gene Engineering Laboratory, Zhejiang University
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
Molecular Genetics, Royal Melbourne Hospital
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
Provincial Medical Genetics Program of British Columbia, University of British Columbia
|
0 |
1
|
0 |
0 |
0 |
0 |
1
|
The information on this website is not intended for direct
diagnostic use or medical decision-making without review by a
genetics professional. Individuals should not change their
health behavior solely on the basis of information contained on
this website. Neither the University of Utah nor the National
Institutes of Health independently verfies the submitted
information. If you have questions about the information
contained on this website, please see a health care
professional.